Yli Remo Vallejo

Dr. Vallejo joined Verax in July 2014. He has 37 years’ experience in the development of various analytical methods and commercial products, the great portion of which involve immunoassay technology. His doctoral thesis covered multi-step organic syntheses leading to pioneering work on the application of immunoassays to pesticide and environmental and food toxicant detection. Dr. Vallejo devoted many years in the medical diagnostics industry as a scientist, manager, director or vice president in such companies as Terumo Medical Corporation, Becton Dickinson, Orasure, American Bio Medica Corporation, and Ensys Environmental, which merged with Newark-based SDI to become SDIX. He has developed many immunoassay-based products in various formats, including many lateral flow tests, for thyroid and other endocrine functions, fertility, infectious diseases, tumor markers, therapeutic drugs, drugs of abuse, allergy, and industrial toxins. For the last 9 years, he worked at ANP Technologies, Inc., becoming its senior vice president for R&D, leading the development of various lateral flow assays for biowarfare agents for the US Department of Defense and Department of Homeland Security, cardiac markers, immunogenicity testing of biotherapeutic drugs, and allergy diagnostics. While at ANP, he invented a rapid test for chemical warfare agents, currently in advanced development for the US Army under a Phase III SBIR grant. Dr. Vallejo is a lead inventor or co-inventor on 5 issued patents and 4 pending applications. He obtained his doctorate in Organic Chemistry from the Pennsylvania State University.